Efficacy endpoints of radiation therapy group protocol 0247: A randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer

Stuart J. Wong, Jennifer Moughan, Neal J. Meropol, Pramila Rani Anne, Lisa A. Kachnic, Asif Rashid, James C. Watson, Edith P. Mitchell, Jondavid Pollock, R. Jeffrey Lee, Michael Haddock, Beth A. Erickson, Christopher G. Willett

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy endpoints of radiation therapy group protocol 0247: A randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy